(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 1.46% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.9%.
Dentsply Sirona's revenue in 2026 is $3,643,000,000.On average, 20 Wall Street analysts forecast XRAY's revenue for 2026 to be $726,445,524,144, with the lowest XRAY revenue forecast at $684,182,502,432, and the highest XRAY revenue forecast at $754,753,774,536. On average, 20 Wall Street analysts forecast XRAY's revenue for 2027 to be $738,805,464,456, with the lowest XRAY revenue forecast at $703,719,182,280, and the highest XRAY revenue forecast at $771,499,500,120.
In 2028, XRAY is forecast to generate $760,335,683,064 in revenue, with the lowest revenue forecast at $716,876,538,096 and the highest revenue forecast at $808,978,028,808.